Using the canine Dysbiosis Index in everyday practice

Canine dysbiosis underpins many chronic gastrointestinal cases in Australian clinics, from Labrador retrievers in suburban Brisbane to working kelpies on rural western New South Wales stations. The Dysbiosis Index has become a practical tool for moving beyond empiric dietary switching toward measured assessment of the gut microbial community. Small animal practitioners are increasingly asked whether a stool test can really explain a months-long history of loose stools.

The tool integrates bacterial taxa, including Faecalibacterium, Turicibacter, Escherichia coli, Streptococcus and Clostridium hiranonis, into a single score. This number distils a complex microbial picture into a pattern that can be weighed alongside clinical findings, faecal scores and protein levels. Understanding both what is measured and what is not is essential before any therapeutic move.

Across busy Australian practice, where caseloads often run from weekend wildlife admissions to senior wellness checks, a result needs to be interpretable in a few minutes between consultations. The Dysbiosis Index is designed precisely for that working environment, producing output that can be discussed with the owner within the same appointment slot. With this mindset, the score becomes a starting point for shared decision-making rather than an endpoint in itself.

Working knowledge of how the index behaves across dog populations continues to grow. International collaborations, including work linked to Texas A&M and the University of Vienna, shape what we know about normal ranges and meaningful shifts. For Australian clinicians, keeping pace matters because local diet patterns, parasitic pressures and urban versus rural living environments shape cases seen on consult days.

Understanding what the index measures

The Dysbiosis Index uses quantitative PCR to compare abundances of selected bacterial groups against reference ranges established from healthy dogs. Most reference ranges suit pet dogs on commercial diets in temperate climates, fitting the urban Australian population in Sydney, Melbourne and Adelaide. A score between 0 and approximately 2 falls within normal limits, while values above this band suggest progressive shifts away from a typical faecal microbiota.

It is worth remembering that the index reflects luminal populations from a single faecal portion. Conditions altering transit time, such as acute haemorrhagic gastroenteritis, will produce readings that may not reflect the steady-state intestinal environment. Similarly, recent courses of antibiotics, proton pump inhibitors or chronic steroid therapy can shift populations and should be weighed into interpretation.

Collecting and shipping samples reliably

The reliability of any index starts before the swab reaches the laboratory. Fresh faecal material less than fifteen minutes old gives the most representative reading. In rural Australia, postal routes are longer, so clinicians often guide owners to freeze samples at minus twenty degrees when immediate dispatch is not possible. Freezing does not alter the targeted taxa used, which helps when couriers run weekly to remote towns.

Recording the patient's diet, recent medications and supplements at submission also strengthens the interpretation. A high-fibre supplement, fenbendazole for giardia, or a Chinese herbal adjunct commonly dispensed in eastern suburbs practices can all alter readings. Clear clinic-side documentation makes the eventual report easier to act upon.

Reading the numerical result

A typical canine Dysbiosis Index report returns the value as a single number, with bands usually described as normal, borderline or significantly elevated. Borderline elevations in clinically well dogs warrant reassessment rather than immediate therapeutic escalation. Marked elevations paired with consistent clinical signs carry far greater weight and justify active intervention. Recent laboratory refinements include sub-scores for individual taxa, allowing clinicians to identify whether a dysbiosis is E. coli-driven, characterised by Turicibacter expansion, or dominated by reduced C. hiranonis.

This granular view helps avoid the trap of treating every abnormal score as identical. A dog with chronic protein-losing enteropathy whose result is driven by C. hiranonis depletion behaves differently from a dog whose abnormality is largely a Turicibacter bloom. Combined reading of the overall score and its components supports better clinical judgement, especially when treatment expectations need to be communicated to owners.

Combining results with clinical findings

No index replaces careful history-taking and physical examination. A Dysbiosis Index sits alongside blood work, faecal flotation, abdominal ultrasound and, where available, fasting bile acid testing to complete the diagnostic picture. Australian clinicians are well accustomed to ruling out regional infectious causes, including Giardia and Salmonella, before considering dysbiosis as a primary contributor. Only when organic disease is appropriately excluded or managed does the index drive direct therapy choices.

In multi-pet households, results can also inform whether a second dog with normal stools should be considered as a sentinel. Family clusters occasionally prompt questions about zoonotic risk or shared dietary triggers, and the index provides a useful framework for those conversations. Discussion of related work, including recent insights into fecal microbiota transplantation, helps clinicians transfer knowledge between species in a structured way.

Translating findings into therapy

Practical therapy usually combines dietary management, microbiome-targeted nutritional support and judicious use of faecal microbial transplant where appropriate. Hydrolysed or novel-protein diets are common first-line choices when inflammatory bowel disease is suspected, and an elevated index reinforces that decision rather than replaces it. Microbiome-modulating nutrition may be layered in, particularly when the result shows persistent abnormality despite dietary change.

Where the index remains stubbornly high and clinical signs persist, referral pathways and ongoing clinical support resources help practitioners navigate the more resistant cases. Choosing between prebiotics, synbiotics, targeted antibiotics or transplant is rarely formulaic, and clinician experience is the deciding variable in most instances.

Tracking response and adjusting the plan

Repeat assessment six to eight weeks after a change is typical, particularly for chronic enteropathy cases at specialist centres or in metropolitan general practices. Trends matter more than isolated readings. A falling index paired with improved faecal scores and stable weight is reassuring. A flat or rising index in a clinically improving dog often points to ongoing subclinical shifts rather than failing therapy. Access to the broader ActivBiome library helps clinicians stay current with evolving interpretations.

Documentation of trends in the patient file, ideally with both numerical values and clinical notes, builds longitudinal records that pay dividends in long cases. Over time, indexed results become part of the story rather than a single event, and that continuous thread is what guides therapy most reliably.